相关实验视频

Updated: Jan 15, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

脂质诊所中的CT冠状动脉造影:试点研究和脂质学家调查

John Graby^1,2, James Sellek³, Ali Khavandi⁴

¹Department of Cardiology, Royal United Hospitals Bath NHS Foundation Trust, Combe Park, Bath, Avon, BA1 3NG, UK. jg2466@bath.ac.uk.

The international journal of cardiovascular imaging

|October 9, 2025

概括

在无症状患者中,冠状动脉CT血管造影 (CCTA) 检测到更多的冠状动脉疾病 (CAD) 和炎症,而不是冠状动脉分数 (CCS). CCTA显著影响临床管理决策,改善了风险分层,而不仅仅是CCS.

科学领域:

心脏病学心脏病学
放射学放射学是一门学科.
预防医学预防医学

背景情况:

冠状动脉评分 (CCS) 建议在无症状个体中进行风险分层.
化是动脉样硬化的晚期阶段,可能缺少早期疾病.
冠状动脉CT血管图 (CCTA) 可以更早地识别非性斑块和炎症.

研究的目的:

在CCS和CCTA之间比较冠状动脉疾病 (CAD) 检测和分级.
与CCS相比,评估CCTA对临床管理的影响.
在脂质临床环境中探索CCTA衍生的炎症生物标志物 (冠状周脂肪衰减指数 (FAI)).

主要方法:

用CCS和CCTA数据 (2018-2020) 对脂质诊所患者数据库的前性分析.
将CCS分级与CCTA衍生的狭窄,高风险斑块 (HRP) 和FAI分数进行比较.
英国顾问脂质学家对连续数据解盲后管理变化的匿名调查.

主要成果:

与CCS (p<0.005) 相比,CCTA重新分类了22%的患者的CAD存在和62%的患者的严重程度.
在20%的患者中发现了高风险斑块 (HRP),其中56%的CCS≤100.
与CCS相比,CCTA显著改变了降脂治疗目标 (19%与12%的变化).

结论:

与CCS相比,CCTA在无症状的脂质诊所患者中提供了优越的CAD检测和分级.
CCTA显著影响临床管理和风险分层.
周冠状动脉脂肪减弱指数 (FAI) 显示出其作为各种CAD严重程度的炎症生物标志物的潜力.

关键词:

心脏成像技术心脏成像技术计算机断层扫描血管学冠状动脉疾病是一种冠状动脉疾病.心脏病的风险因素心脏病的风险因素超脂血症症是一种超脂血症.

更多相关视频

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

相关概念视频

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...